ANN PARKER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BOWIE, MD NPI 1588965784

General Payments — all program years on this page

$1,632.76

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 50
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $395.45 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $395.4517

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $185.085
2022 $374.1713
2023 $678.0615
2024 $395.4517

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1107788592 ABBVIE INC. $17.93 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107788597 ABBVIE INC. $26.56 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113645645 Intercept Pharmaceuticals, Inc. $19.97 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140480494 Melinta Therapeutics, LLC $15.72 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140480570 Melinta Therapeutics, LLC $15.83 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144196819 Madrigal Pharmaceuticals $20.24 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145181625 Mallinckrodt Hospital Products Inc. $34.70 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145181629 Mallinckrodt Hospital Products Inc. $26.24 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147094379 Veloxis Pharmaceuticals, Inc. $33.92 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147094381 Veloxis Pharmaceuticals, Inc. $19.02 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150699757 Aurinia Pharma U.S., Inc. $24.12 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153496264 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.03 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153534662 Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.30 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153581497 Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.19 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153646974 Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.93 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153651592 Salix Pharmaceuticals, a division of Bausch Health US, LLC $28.57 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153677716 Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.18 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.